The human african trypanosomiasis control and surveillance programme of the world health organization 2000-2009: The way forward

PLoS Neglected Tropical Diseases

Volumn 5, Issue 2, 2011, Pages

  Simarro, Pere P ^a   Diarra, Abdoulaye ^a   Postigo, Jose A Ruiz ^a   Franco, José R ^a   Jannin, Jean G ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; MELARSOPROL; NIFURTIMOX;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CHAGAS DISEASE; DIAGNOSTIC TEST; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MONOTHERAPY; POLICY; SEASONAL VARIATION; WORLD HEALTH ORGANIZATION; ENDEMIC DISEASE; GEOGRAPHY; INCIDENCE; METHODOLOGY; ORGANIZATION AND MANAGEMENT;

COMMUNICABLE DISEASE CONTROL; ENDEMIC DISEASES; GEOGRAPHY; HUMANS; INCIDENCE; TRYPANOSOMIASIS, AFRICAN; WORLD HEALTH ORGANIZATION;

EID: 79952459914     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001007     Document Type: Article

References (29)

1. Magnus E, Vervoot T, Van Neirvenne N, (1978) A card agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann Soc Belg Med Trop 58: 169-176.
2. Smith DH, Pepin J, Stich AH, (1998) Human African trypanosomiasis: an emerging public health crisis. Br Med Bull 54: 341-355.
3. Stich A, Barrett MP, Krishna S, (2003) Waking up to sleeping sickness. Trends Parasitol 19: 195-197.
4. Sjoerdsma A, Schechter PJ, (1999) Eflornithine for African sleeping sickness. Lancet 354: 254.
5. World Health Organization (1998) Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. WHO technical report series 881 Geneva World Health Organization.
6. World Health Organization (1997) Resolution 50.36 on African trypanosomiasis. 50th World Health Assembly Geneva World Health Organization.
7. World Health Organization (2009) Improving access to the best treatment for second stage T.b.gambiense. Available: http://www.who.int/neglected_diseases/disease_management/hat_access_treatment/en/index.html. Accessed 27 January 2011.
8. Van Nieuwenhove S, Declercq J, (1981) Nifurtimox (Lampit) treatment in late stage of gambiense sleeping sickness. In: Proceedings of the 17th meeting of ISCTRC; 1981; Arusha, Tanzania. Publication N° 112: 206-208.
9. Pepin J, Milord F, Mpia B, Meurice F, Ethier L, et al. (1989) An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire. Trans Roy Soc Trop Med & Hyg 83: 514-517.
10. Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, et al. (2007) Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 195: 322-329.
11. Priotto G, Fogg C, Balasegaram M, Erphas O, Louga A, et al. (2006) Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials 1: e39 doi:10.1371/journal.pctr.0010039.
12. Checchi F, Piola P, Ayikoru H, Thomas F, Legros D, et al. (2007) Nifurtimox plus efl ornithine for late-stage sleeping sickness in Uganda: a case series. PLoS Negl Trop Dis 1: e64 doi:10.1371/journal.pntd.0000064.
13. Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, et al. (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicenter, randomized, phase III, non-inferiority trial. Lancet 374: 56-64.
14. World Health Organization (2009) WHO includes combination of eflornithine and nifurtimox in its Essential List of Medicines for the treatment of human African trypanosomiasis. Available: http://www.who.int/neglected_diseases/disease_management/drug_combination/en/index.html. Accessed 27 January 2011.
15. World Health Organization (2010) Nifurtimox-eflornithine combination treatment for sleeping sickness (human African trypanosomiasis): WHO wraps up training of key health care personnel. Available: http://www.who.int/trypanosomiasis_african/research/combination_treatment/en/index.html. Accessed 27 January 2011.
16. World Health Organization (2009) WHO rolls out new combination treatment for sleeping sickness. Available: http://www.who.int/neglected_diseases/disease_management/new_sleeping_sickness_treatment/en/index.html. Accessed 27 January 2011.
17. Simarro PP, Cecchi G, Paone M, Franco JR Diarra A, et al. (2010) The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 9: 57.
18. World Health Organization (2010) Human African trypanosomiasis: number of new cases drops to historically low level in 50 years. Available: http://www.who.int/neglected_diseases/integrated_media/integrated_media_hat_june_2010/en/index.html. Accessed 27 January 2011.
19. Kgori PM, Modo S, Torr SJ, (2006) The use of aerial spraying to eliminate tsetse from the Okavango Delta of Botswana. Acta Trop 99: 184-199.
20. Kgori PM, Modo S, (2009) Transboundary programme to eliminate tsetse from the River frontiers of Botswana and Namibia using the sequential aerial spraying technique. Proceedings of the 30th Meeting of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC); 2009; Kampala, Uganda.
21. Saini RK, Simarro PP, (2008) Tsetse survey in Swaziland. Report for the World Health Organization. Available: http://www.who.int/trypanosomiasis_african/resources/The_HAT_atlas.pdf. Accessed 27 January 2011.
22. [No authors listed] (2006) Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 81: 71-80.
23. Chappuis F, Lima MA, Flevaud L, Ritmeijer K, (2010) Human African trypanosomiasis in areas without surveillance. Emerg Infect Dis 16: 354-356.
24. Fèvre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, et al. (2001) The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet 358: 625-628.
25. Kabasa JD, (2007) Public-private partnership works to stamp out sleeping sickness in Uganda. Trends Parasitol 23: 191-192.
26. Cecchi G, Courtin F, Paone M, Diarra A, Franco JR, et al. (2009) Mapping sleeping sickness in Western Africa in a context of demographic transition and climate change. Parasite 16: 99-106.
27. Courtin F, Jamonneau V, Duvallet G, Garcia A, Coulibaly B, et al. (2008) Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past. Trop Med Int Health 13: 334-344 Available: http://dx.doi.org/10.1111/j.1365-3156.2008.02007.x. Accessed 27 January 2011.
28. World Health Organization (2007) Report of a WHO Informal Consultation on sustainable control of human Afican trypanososmiasis. 1-3 May 2007, Geneva, Switzerland Available: http://whqlibdoc.who.int/hq/2007/WHO_CDS_NTD_IDM_2007.6_eng.pdf. Accessed 27 January 2011.
29. World Health Organization (2010) Control of neglected tropical diseases is feasible. Renewed engagement to scale-up integrated interventions announced [press release]. Available: http://www.who.int/mediacentre/news/releases/2010/ntd_20101014/en/index.html. Accessed 27 January 2011.